Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β
Steve Simpson(University of Tasmania), Tomáš Kalinčík(The Royal Melbourne Hospital), Tim Spelman(Peter Doherty Institute), Lotte Geys(Hasselt University), Stefan Braune, Sifat Sharmin(The Royal Melbourne Hospital), Edward De Brouwer(KU Leuven), Ruth Dobson(Queen Mary University of London), Richard Nicholas(Swansea University), Ricardo Alonso(Hospital Ramos Mejía), Anne Helme(Multiple Sclerosis International Federation), Amber Salter(Salter School), Helmut Butzkueven(Monash Alfred Psychiatry Research centre), Lars Costers(Mental Health Research Institute), Bruce F. Bebo(National Multiple Sclerosis Society), Yves Moreau(Dynamic Systems (United States)), Anneke van der Walt(The Alfred Hospital), Juan Ignacio Rojas(Hospital Universitario Austral), Gıancarlo Comı(Vita-Salute San Raffaele University), Alexander Stahmann(Unknown), Aníbal Chertcoff(Hospital Británico de Buenos Aires), Raed Alroughani(Amiri Hospital), Cavit Boz(Farabi Hastanesi), Robert McBurney(Accelerated Cure Project for Multiple Sclerosis), Jan Hillert, Ana Zabalza(Universitat Autònoma de Barcelona), Liesbet M. Peeters(Hasselt University), Ashkan Pirmani(Hasselt University), Paulo Rogério Melo Rodrigues, Ingrid van der Mei(University of Tasmania), Rana Karabudak(Hacettepe University), Tina Parciak(Universitätsmedizin Göttingen), A. Descamps(Mental Health Research Institute), Georgina Arrambide(Universitat Autònoma de Barcelona), Nupur Nag(Mental Health Research Institute), Gilles Edan(Centre National de la Recherche Scientifique), Guilherme Sciascia do Olival(Brazilian Medical Association), Vesna Prčkovska(Mental Health Research Institute), Serkan Özakbaş(İzmir University of Economics), Hollie Schmidt(Research Network (United States)), Aleisha Miller(Mental Health Research Institute), Rod Middleton(Swansea University), Arnfin Bergmann, Melinda Magyari(University of Copenhagen)
Cited by 7
Related Papers
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
|Multiple Sclerosis Journal|2020|2.5k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k